| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.384 | 21.670 | - | 20.912 | 20.507 | 37.111 | 36.288 | 36.400 | 36.290 | 36.087 |
| Total Income - EUR | 40.386 | 21.671 | - | 20.914 | 20.509 | 37.113 | 36.290 | 36.402 | 36.292 | 36.089 |
| Total Expenses - EUR | 29.714 | 32.912 | - | 31.761 | 31.146 | 27.305 | 26.699 | 26.782 | 26.701 | 26.552 |
| Gross Profit/Loss - EUR | 10.673 | -11.241 | - | -10.848 | -10.637 | 9.808 | 9.590 | 9.620 | 9.591 | 9.537 |
| Net Profit/Loss - EUR | 9.461 | -11.454 | - | -11.054 | -10.840 | 8.694 | 8.501 | 8.528 | 8.502 | 8.454 |
| Employees | 3 | 3 | - | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Tavetana Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 36.541 | 29.884 | - | 28.839 | 28.281 | 33.579 | 32.834 | 32.936 | 32.836 | 32.652 |
| Current Assets | 28.517 | 24.008 | - | 23.169 | 22.720 | 26.205 | 25.624 | 25.704 | 25.626 | 25.483 |
| Inventories | 3.117 | 2.322 | - | 2.241 | 2.197 | 2.864 | 2.800 | 2.809 | 2.801 | 2.785 |
| Receivables | 16.469 | 18.456 | - | 17.811 | 17.466 | 15.134 | 14.798 | 14.844 | 14.799 | 14.716 |
| Cash | 8.932 | 3.229 | - | 3.117 | 3.056 | 8.208 | 8.026 | 8.050 | 8.026 | 7.981 |
| Shareholders Funds | 33.549 | 21.752 | - | 20.992 | 20.585 | 30.829 | 30.146 | 30.239 | 30.147 | 29.979 |
| Social Capital | 112 | 111 | - | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 31.509 | 32.140 | - | 31.016 | 30.416 | 28.955 | 28.313 | 28.400 | 28.314 | 28.156 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Tavetana Med S.r.l.